Guru Ownership Trend
Guru Analysis for Palvella Therapeutics, Inc. (PVLA)
Palvella Therapeutics, Inc. (PVLA), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $15.66 M.
Top institutional holders include Renaissance Technologies (RenTech) and Chuck Royce.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $2.66 M net outflow during the quarter.
Recent activity highlights Renaissance Technologies (RenTech) who increased their stake by 196.4%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Palvella Therapeutics, Inc. (PVLA)
Major holders include Renaissance Technologies (RenTech) ($8.14 M), Chuck Royce ($6.19 M), Paul Tudor Jones ($1.21 M). According to the latest reported data, 4 tracked investment managers collectively hold approximately 104,001 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $2.66 M, with 4 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 0 managers trimmed their positions, while 1 fully exited PVLA. The total reported sell value was $10.99 M.
Yes, 2 managers opened new positions in PVLA, and 2 increased their existing holdings. The total reported buy value was $8.33 M.